FDA adds rare vision-loss warning to popular GLP-1 drugs
Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday.
Comments are closed.